• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 141
  • 78
  • 43
  • 9
  • 9
  • 7
  • 6
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • Tagged with
  • 336
  • 86
  • 73
  • 70
  • 46
  • 45
  • 45
  • 43
  • 40
  • 34
  • 31
  • 30
  • 28
  • 23
  • 22
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
1

Studies on co-stimulatory molecules, chemokines and chemokine receptors in neuroimmunological diseases /

Teleshova, Natalia, January 1900 (has links)
Diss. (sammanfattning) Stockholm : Karol. inst., 2001. / Härtill 5 uppsatser.
2

Role of homocysteine in the expression of monocyte Chemoattractant protein-1 (MCP-1)

宋蘭。, Sung, Lan, Fion. January 1999 (has links)
published_or_final_version / Pharmacology / Master / Master of Philosophy
3

Role of homocysteine in the expression of monocyte Chemoattractant protein-1 (MCP-1) /

Sung, Lan, Fion. January 1999 (has links)
Thesis (M. Phil.)--University of Hong Kong, 1999. / Includes bibliographical references (leaves 86-110).
4

The role of Chemerin and ChemR23 in invasiveness of gastric cancer. / CUHK electronic theses & dissertations collection

January 2012 (has links)
Chemerin是一種新近發現的脂肪因數,其與肥胖,代謝綜合症和炎症密切相關。Chemerin通過G蛋白偶聯受體ChemR23 發揮生物學效應。脂肪組織為分泌型Chemerin的最主要來源。最近的研究顯示Chemerin 可能與腫瘤的發生相關。本研究的目的在於確定胃癌細胞上是否存在ChemR23,以及Chemerin/ChemR23 在腫瘤侵襲過程中的作用。 / 我們首先用western blot和免疫組織化學技術在人腫瘤組織及兩株腫瘤細胞AGS和MKN28上尋找ChemR23。我們首次證實ChemR23 在胃癌細胞上表達。 / 既往研究表明,炎症因數IL-6 可上調人類內皮細胞上表達的ChemR23。為了證明IL-6 對胃癌細胞表達ChemR23的調節作用,我們將兩株胃癌細胞培養於含有不同濃度的Chemerin 的溶液中。研究證明IL-6 對於ChemR23 的表達具有濃度和時間依賴性的上調作用。 / 接下來,我們關注於Chemrin/ChemR23 在VEGF,MMP-7和IL-6 表達中的作用。我們將胃癌細胞用含有或者不含有Chemerin的溶液培養,進而測量VEGF ,MMP-7和IL-6 的表達量。進而我們將研究Chemerin 對mammalian family of mitogen-activated protein kinases (MAPKs)即:Erk,P38,Jnk的調節作用,MAPKs對於VEGF,MMP-7和IL-6 的產生起著重要的作用。我們發現Chemerin對VEGF,MMP-7和IL-6 的上調作用具有濃度和時間依賴性。Chemrin對MAPKs的啟動亦具有時間依賴性。MAPKs抑制劑可減弱Chemein相關的VEGF, MMP-7和IL-6的生成。 / 因為VEGF,MMP-7和IL-6與腫瘤的侵襲相關,我們進一步對Chemerin 在腫瘤轉移中的作用進行探索。我們使用transwell實驗工具盒來檢測腫瘤的侵襲能力。我們將AGS或MKN28細胞懸液裡加入不同濃度的Chemerin,結果是Chemerin增強腫瘤的侵襲能力(P<0.001)。為了驗證chemeri 引發的腫瘤侵襲是否通過MAPKs信號通路,我們將AGS和MKN28細胞用MAPK抑制劑處理2小時候,再加入Chemerin 0.1ng/ml。結果是Chemerin引發的腫瘤細胞侵襲可被MAPK抑制劑所抑制。 / 隨後,我們將探索人血清Chemerin濃度是否與胃癌TNM分型及組織學分型相關。研究包括36例胃癌患者的血清。TNM分型與組織病理檢查及臨床評估為依據。對於組織分型的分析,患者分為兩組,腸型和非腸型。人血清Chemerin濃度用Elisa方法測定。用one way ANOVA 進行統計學分析, II,III+IV型胃癌患者血清 Chemrin濃度明顯高於I型患者. 用獨立樣本 T test 分析,結果是非腸型胃癌患者血清Chemerin 濃度 明顯高於腸型患者 (P<0.05) / 總之,我們首次證明了胃癌細胞表達ChemR23。Chemerin /ChemR23 對腫瘤細胞分泌VEGF,MMP-7 和IL-6具有重要上調作用,該作用通過MAPKs信號通路實現。人類血清Chemerin濃度與胃癌患者TNM分析及組織性分型相關。Chemerin 可被看作是促進腫瘤侵襲的因素之一。 / Chemerin is a newly discovered adipokine which is closely associated with obesity, metabolic syndrome, and inflammatory conditions. It acts via its distinct G protein-coupled receptor ChemR23. While Chemerin is predominantly released by adipocytes, recent studies have also shown its possible correlation with carcinogenesis. This thesis aims to determine whether ChemR23 is expressed in gastric cancer, and to clarify the roles of Chemerin/ChemR23 in the invasive capacity of gastric carcinoma. / We first started by investigating the native expression of ChemR23 in human gastric cancer tissue samples and two gastric cancer cell lines, namely AGS and MKN28, using immunohistochemistry and Western blot techniques. In this set of initial experiments, ChemR23 was found to be present in gastric cancer cells with different magnitudes of expression. / Previous studies have also shown that ChemR23 synthesis in human endothelial cells was upregulatable by proinflammatory cytokines, such as IL-6. We thus investigated the biological effect of IL-6 on ChemeR23 expression in gastric cancer. By incubating the two cell lines with different concentration of recombinant IL-6, a dose- and time- dependent upregulation of ChemR23 expression was seen in both MKN28 and AGS. / We next sought to investigate the effect of Chemerin/ChemR23 on VEGF,MMP-7 and IL-6 expression. Gastric cancer cells were cultured with or without recombinant Chemerin. Corresponding VEGF, MMP-7 and IL-6 expressions were measured at sequential time points. In addition, the effect of Chemrerin on activation of mammalian family of mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinase (ERK), P38MAPK, and c-Jun NH(2)-terminal kinase (JNK), which play a key role in VEGF, MMP-7 and IL-6 expression, was determined. Our Results revealed that Chemerin induced VEGF, MMP-7 and IL-6 expressions in gastric cancer cells in a dose- and time- dependent manner, and such an effect was reversible by MAPK inhibitors. / As VEGF, MMP-7, IL-6 are known to be associated with invasion of cancer, we therefore proceeded to determine whether Chemerin had any effect on invasiveness of gastric cancer in vitro. Commercial transwell invasion chambers were used. We found that Chemerin up-regulated the ability of invasion of gastric cancer (P<0.001). To test whether Chemerin induced gastric cancer cells invasion was mediated through MAPKs pathway, we pretreated AGS and MKN28 with or without MAPKs inhibitors 2 hours before adding Chemerin. This experiment proved that Chemerin enhanced cancer invasions were reversible by MAPK inhibitor. / In the last part of this project, the correlation between human serum Chemerin level and TNM stage/ histology of clinically collected gastric cancer samples was analyzed. This study included 36 gastric cancer patients. The cancer staging was based on a routine histopathological assessment according to the 6th UICC TNM (tumor-nodulus-metastases) system. One way ANOVA analysis showed that the mean Chemerin levels of stage II and III+IV groups were significantly higher than that of stage I cases. When serum Chemerin level was analyzed according to Lauren’s histological subtypes of the tumours, it was found to be significantly higher in the non-intestinal group when compared to the intestinal group. (P<0.05) / In conclusion, I have demonstrated for the first time that ChemR23 is expressed by gastric cancer cells. Chemerin/ChemR23 has upregulating effect on VEGF, MMP-7and IL-6 expression through the MAPK pathways. The invasive capacity of gastric cancer was significantly potentiated by Chemerin in vitro. The serum Chemerin level also has correlation with TNM stage and histology of gastric cancer. So Chemerin may be a functional onco-protein modulating the invasiveness of human gastric cancer. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Wang, Chunhu. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2012. / Includes bibliographical references (leaves 129-138). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese. / ABSTRACT --- p.II / ACKNOWLEDGEMENTS --- p.VII / LIST OF ABBREVIATIONS --- p.VIII / LIST OF FIGURES --- p.IX / LIST OF TABLES --- p.XI / Chapter Chapter 1 --- Introduction --- p.1 / Chapter 1.1 --- General introduction of Gastric Cancer --- p.1 / Chapter 1.1.1 --- Epidemiology --- p.1 / Chapter 1.1.2 --- Risk Factors --- p.2 / Chapter 1.1.3 --- Therapy --- p.6 / Chapter 1.2 --- Gastric cancer invasion --- p.8 / Chapter 1.2.1 --- The role of mitogen activated protein kinases (MAPKs) and other signaling pathways in gastric cancer invasion --- p.9 / Chapter 1.2.2 --- VEGF, MMP-7 and IL-6 and their roles in gastric cancer invasion --- p.14 / Chapter 1.3 --- Novel mediators: Chemerin/ChemR23 --- p.16 / Chapter 1.3.1 --- What is Chemerin and ChemR23 --- p.17 / Chapter 1.3.2 --- The role of Chemerin/ChemR23 in pathological conditions --- p.20 / Chapter 2.1 --- Experiment 1 :ChemR23 expression in gastric cancer --- p.24 / Chapter 2.1.1 --- Materials and methods --- p.24 / Chapter 2.1.2 --- Results --- p.26 / Chapter 2.2 --- Experiment 2: In vitro ChemR23 expression in Gastric Cancer cell culture and its interaction with IL-6 --- p.32 / Chapter 2.2.1 --- Materials and methods --- p.32 / Chapter 2.2.2 --- Results: --- p.35 / Chapter 2.3 --- Discussion --- p.45 / Chapter Chapter 3 --- Chemerin activates FAK, MAPK and Akt signal pathway on gastric cancer --- p.50 / Chapter 3.1 --- Materials and methods --- p.50 / Chapter 3.1.1 --- Reagents and antibodies: --- p.51 / Chapter 3.1.2 --- Cell cultures and treatment --- p.51 / Chapter 3.1.3 --- MTT assay for the effect of Chemerin on gastric cancer proliferation --- p.52 / Chapter 3.1.4 --- ChemR23 siRNA transfection --- p.52 / Chapter 3.1.5 --- Western blot analysis. --- p.53 / Chapter 3.1.5 --- Statistical analysis. --- p.54 / Chapter 3.2 --- Results --- p.54 / Chapter 3.2.1 --- MTT assay result --- p.54 / Chapter 3.2.2 --- Chemerin activates FAK signal pathways --- p.56 / Chapter 3.2.3 --- Chemerin activate MAPK signal pathways --- p.58 / Chapter 3.2.4 --- Chemerin induced Akt activation --- p.63 / Chapter 3.2.5 --- Chemerin activates MAPK pathways through ChemR23 --- p.65 / Chapter 3.3 --- Discussion --- p.69 / Chapter Chapter 4 --- Chemerin up-regulates VEGF, MMP-7 and IL-6 expression throug MAPK pathway on gastric cancer --- p.73 / Chapter 4.1 --- Materials and methods --- p.73 / Chapter 4.1.1 --- Reagents and antibodies: --- p.73 / Chapter 4.1.2 --- Cell cultures and treatment --- p.74 / Chapter 4.1.3 --- ChemR23 siRNA transfection --- p.74 / Chapter 4.1.4 --- Treatment MAPK inhibitors --- p.75 / Chapter 4.1.5 --- uantitative reverse transcript (RT)-PCR assay --- p.75 / Chapter 4.1.6 --- Western blot analysis --- p.76 / Chapter 4.1.7 --- Statistical analysis. --- p.77 / Chapter 4.2 --- Results --- p.78 / Chapter 4.2.1 --- Chemerin up-regulated VEGF, MMP-7, IL-6 expression --- p.78 / Chapter 4.2.2 --- Chemerin induced VEGF and MMP-7expression through ChemR23 --- p.87 / Chapter 4.2.3 --- Chemerin induced VEGF, MMP-7 and IL-6 expression through MAPK pathways --- p.91 / Chapter 4.3 --- Discussion: --- p.96 / Chapter Chapter 5 --- Chemerin enhances gastric cancer invasiveness through the MAPK pathways --- p.100 / Chapter 5.1 --- Materials and methods --- p.100 / Chapter 5.1.1 --- Reagents and antibodies: --- p.100 / Chapter 5.1.2 --- Cell culture and treatments --- p.101 / Chapter 5.1.3 --- Tumor invasion potential evaluated with Transwell invasion chambers --- p.101 / Chapter 5.1.4 --- Statistical analysis. --- p.102 / Chapter 5.2 --- Results: --- p.103 / Chapter 5.2.1 --- Chemerin increased gastric cancer cells invasion abilities --- p.103 / Chapter 5.2.2 --- Chemerin increased gastric cancer cells invasion abilities through MAPK pathways --- p.104 / Chapter 5.3 --- Discussion: --- p.109 / Chapter Chapter 6 --- Chemerin relates with TNM stage and histology of gastric cancer --- p.113 / Chapter 6.1 --- Materials and methods --- p.113 / Chapter 6.1.1 --- Study population --- p.113 / Chapter 6.1.2 --- Serum Chemerin level measurements --- p.114 / Chapter 6.1.3 --- Statistical analysis --- p.115 / Chapter 6.2 --- Results: --- p.115 / Chapter 6.2.1 --- Serum Chemerin level in healthy subject plus gastric cancer patients followed normal distribution but did not follow homogeneity of variances --- p.115 / Chapter 6.2.2 --- Serum Chemerin level in gastric cancer patients was higher than healthy subjects --- p.116 / Chapter 6.2.3 --- Serum Chemerin level in gastric cancer followed normal distribution and homogeneity of variances --- p.120 / Chapter 6.2.4 --- Human serum Chemerin level was related to gastric cancer TNM stage --- p.121 / Chapter 6.2.5 --- Association between human serum Chemerin level and histology --- p.123 / Chapter 6.3 --- Discussion --- p.125 / Chapter Chapter 7: --- Conclusion and future plan --- p.127 / Reference --- p.129
5

Mammalian and viral chemokines provide insight into the mechanism of chemokine receptor activation

Davis, Christopher Nathan, January 2004 (has links)
Thesis (Ph. D.)--University of Florida, 2004. / Title from title page of source document. Document formatted into pages; contains 145 pages. Includes vita. Includes bibliographical references.
6

Macrophage inflammatory protein-1#alpha# : an inhibitor of clonogenic epidermal keratinocyte proliferation?

Bono, Johann S. de January 1998 (has links)
No description available.
7

Inflammation-Induced Plasticity of Micturition Reflex Pathways

Arms, Lauren 19 July 2011 (has links)
Although a seemingly basic and simple behavior, micturition necessitates precise integration and coordination of multiple divisions of the nervous system: visceral sensory, somatic motor, sympathetic, parasympathetic, as well as voluntary control from higher brain/ brainstem centers. When coordination of this circuitry falters, the consequences can be devastating and include severely decreased quality of life and substantial economic burden. This dissertation project investigates the potential role(s) of inflammatory mediators in bladder sensory physiology with the long term goal of elucidating potential targets for intervention. The overall hypothesis is that inflammatory-induced changes in the urinary bladder or afferent projections ultimately lead to dysfunctional micturition symptoms. Using a rodent model of cyclophosphamide (CYP)-induced bladder inflammation, we examined the expression and function of the chemokine/ receptor pair, CXCL12/CXCR4, and the activated (phosphorylated) form of ubiquitous signaling molecule, AKT using a multidisciplinary approach that includes: immunohistochemistry, protein and transcript quantification techniques, and in vivo bladder physiology studies combined with pharmacological tools. Peripheral chemokine levels are elevated in patients with various chronic pelvic inflammatory/ pain syndromes including interstitial cystitis/bladder pain syndrome (IC/BPS) and are implicated in numerous inflammatory and mechanical pain models in rodents. However studies had not previously shown a direct functional role for chemokine signaling in micturition. We hypothesized that CXCL12 and CXCR4 would increase in the urinary bladder with CYP-induced bladder inflammation and that CXCR4 receptor blockade with AMD3100 would reduce CYP-induced bladder hyperreflexia. ELISA, immunohistochemical and qRT-PCR experiments demonstrate duration-dependent increases in CXCL12 and CXCR4 protein and transcript expression in specific tissue compartments of the urinary bladder, mainly the urothelium. In vivo studies provide evidence of a role for chemokine signaling in the mediation of micturition function. Intravesical infusion with AMD3100, a CXCR4 receptor antagonist, significantly reduced CYP-induced bladder hyperreflexia as evidenced by increased bladder capacity, intercontraction interval and decreased voiding frequency. AKT is a putative cellular survival signal, however, recent studies also implicate the signaling molecule in the induction and maintenance of pain processes, development of long term plasticity (e.g. LTP and central sensitization) and visceral inflammation. Functional studies addressing the contribution of pAKT in micturition have not been performed. We hypothesized that increasing pAKT levels would contribute to CYP-induced bladder hyperreflexia. Western blot and immunohistochemical studies demonstrated that phosphorylation of AKT increases in the whole urinary bladder with CYP-induced bladder inflammation in a tissue compartment- and time-dependent manner. Intravesical infusion with inhibitors of AKT phosphorylation, AKT Inhibitor IV and deguelin, significantly improved symptoms of CYP-induced bladder hyperreflexia suggesting a functional role for pAKT in bladder physiology. These studies demonstrate the functional capacity of inflammatory mediators and inflammatory associated signaling pathways in micturition reflex pathways. Chemokine signaling via the CXCR4 receptor and upstream activators of AKT may provide therapeutic targets with respect to inflammatory-induced bladder sensory physiology dysfunction.
8

The contributions of murine KC and MIP-2 in hemorrhage induced neutrophil priming for acute lung injury following subsequent septic challenge /

Lomas-Neira, Joanne Lemay. January 2006 (has links)
Thesis (Ph. D.)--University of Rhode Island, 2006. / Typescript. Includes bibliographical references (leaves 162-177).
9

Etude des activités anti- et pro-tumorales d'agents chimioattractants et de leurs récepteurs leucocytaires./Analysis of the anti- and pro-tumoral activities of chemoattractant agents and their leukocyte receptors.

Sutherland, Audrey 08 September 2008 (has links)
Les chimiokines, petites protéines sécrétées par de nombreux types cellulaires, régulent le trafic et la fonction des populations leucocytaires en interagissant avec leurs récepteurs spécifiques, qui appartiennent à la superfamille des récepteurs à 7 domaines transmembranaires couplés aux protéines G. Dans le contexte tumoral, les chimiokines jouent des rôles ambivalents, en régulant le recrutement des leucocytes, ainsi que la croissance et l’angiogenèse des tumeurs. Aussi, les chimiokines semblent également contribuer à déterminer les sites métastatiques des tumeurs malignes. Notre travail porte sur l’étude du rôle de chimiokines et récepteurs, fréquemment exprimés au sein de tumeurs, dans un modèle tumoral chez la souris, la lignée cellulaire LLC (Lewis Lung Carcinoma). Chaque gène d’intérêt (CCR3, CCR6, CCR7, CXCR4, CXCR5, CCL19, CCL20, CCL21, CXCL13) a été exprimé dans la lignée LLC, ces différentes lignées ont été greffées à des souris syngéniques, et les caractéristiques phénotypiques des tumeurs ont été analysées, notamment la croissance tumorale, la fréquence et la distribution des métastases, et l’importance des réactions immunitaires de l’hôte. Nous avons montré que la croissance tumorale n’est pas affectée par l’expression des différents récepteurs étudiés, ni par celle des chimiokines CCL19 et CCL21, alors que l’expression de CXCL13 et de CCL20 par les cellules LLC réduit leur croissance in vivo. La quantification des métastases pulmonaires a montré que l’expression de CCR3, CXCR5, CCR7, CCL19 ou CCL21 par les cellules tumorales n’affecte pas significativement le potentiel métastatique des cellules LLC. Par contre, l’expression de CXCR4 entraîne une augmentation, et CCR6 une diminution, du nombre de métastases pulmonaires. La diminution du potentiel métastatique des tumeurs LLC/CCR6 implique notamment l’augmentation des propriétés d’adhésion de ces cellules. Les cellules LLC produisent naturellement de petites quantités du ligand CCL20. Nous postulons que la stimulation autocrine de CCR6 par CCL20 dans ces cellules in vivo augmente leurs propriétés d’adhésion et diminue leur potentiel métastatique. Dans le contexte de l’implication des chimiokines et récepteurs dans la détermination des sites métastatiques, nous proposons dès lors un modèle plus général : les récepteurs aux chimiokines dirigent les cellules tumorales vers les sites métastatiques où est produit le ligand correspondant ; cependant, si le ligand est produit au niveau de la tumeur, il favorise le maintien des cellules tumorales au niveau du site primaire. L’effet anti-tumoral de CCL20 ne dépend apparemment pas d’un recrutement plus important de cellules dendritiques, de lymphocytes T et de cellules NK exprimant le récepteur CCR6. Nos observations suggèrent plutôt un effet de CCL20 sur l’angiogenèse tumorale.
10

Regulation of monocyte chemoattractant protein-1 expression in macrophages

Yip, Chin-wing, Johnny., 葉展榮. January 2003 (has links)
published_or_final_version / abstract / toc / Pharmacology / Master / Master of Philosophy

Page generated in 0.0645 seconds